Molecular Mechanisms of Flavonoids against Tumor Gamma-Herpesviruses and Their Correlated Cancers—A Focus on EBV and KSHV Life Cycles and Carcinogenesis
暂无分享,去创建一个
[1] P. Kubatka,et al. Insights into Antiviral Properties and Molecular Mechanisms of Non-Flavonoid Polyphenols against Human Herpesviruses , 2022, International journal of molecular sciences.
[2] H. Oberwinkler,et al. A defined anthocyanin mixture sourced from bilberry and black currant inhibits Measles virus and various herpesviruses , 2022, BMC Complementary Medicine and Therapies.
[3] A. Ghram,et al. Thymus capitatus flavonoids inhibit infection of Kaposi's sarcoma‐associated herpesvirus , 2022, FEBS open bio.
[4] P. Kubatka,et al. Flavonoids Target Human Herpesviruses That Infect the Nervous System: Mechanisms of Action and Therapeutic Insights , 2022, Viruses.
[5] Li Wang,et al. Plant flavonoids: Classification, distribution, biosynthesis, and antioxidant activity. , 2022, Food chemistry.
[6] Heng-fu Yin,et al. The Flavonoid Biosynthesis Network in Plants , 2021, International journal of molecular sciences.
[7] Guo-Hua Zhao,et al. Hesperetin inhibits KSHV reactivation and is reversed by HIF1α overexpression. , 2021, The Journal of general virology.
[8] G. Orrù,et al. Quercetin and its derivates as antiviral potentials: A comprehensive review , 2021, Phytotherapy research : PTR.
[9] B. Damania,et al. Cancers associated with human gammaherpesviruses , 2021, The FEBS journal.
[10] Artur M. S. Silva,et al. Plant Flavonoids: Chemical Characteristics and Biological Activity , 2021, Molecules.
[11] B. Damania,et al. Activation and evasion of innate immunity by gammaherpesviruses. , 2021, Journal of molecular biology.
[12] H. Jha,et al. Identification of Potential Inhibitors against Epstein-Barr Virus Nuclear Antigen 1 (EBNA1): An Insight from Docking and Molecular Dynamic Simulations. , 2021, ACS chemical neuroscience.
[13] A. Farooqi,et al. Cancer chemopreventive role of fisetin: Regulation of cell signaling pathways in different cancers. , 2021, Pharmacological research.
[14] M. Gaglia. Kaposi's sarcoma-associated herpesvirus at 27 , 2021, Tumour virus research.
[15] P. Kubatka,et al. Berberine in Human Oncogenic Herpesvirus Infections and Their Linked Cancers , 2021, Viruses.
[16] M. Shakibaei,et al. Flavonoids as an effective sensitizer for anti-cancer therapy: insights into multi-faceted mechanisms and applicability towards individualized patient profiles , 2021, EPMA Journal.
[17] C. Münz. The Role of Lytic Infection for Lymphomagenesis of Human γ-Herpesviruses , 2021, Frontiers in Cellular and Infection Microbiology.
[18] M. Healy,et al. Infectious Mononucleosis: diagnosis and clinical interpretation , 2021, British journal of biomedical science.
[19] Z. Fasoulakis,et al. Breast Cancer Apoptosis and the Therapeutic Role of Luteolin. , 2021, Chirurgia.
[20] H. Lung,et al. The Role of EBV-Encoded LMP1 in the NPC Tumor Microenvironment: From Function to Therapy , 2021, Frontiers in Oncology.
[21] A. Bode,et al. (−)-Epigallocatechin-3-Gallate Inhibits EBV Lytic Replication via Targeting LMP1-Mediated MAPK Signal Axes , 2021, Oncology research.
[22] Miroslava Šudomová,et al. Nutraceutical Curcumin with Promising Protection against Herpesvirus Infections and Their Associated Inflammation: Mechanisms and Pathways , 2021, Microorganisms.
[23] R. Bauer,et al. Natural products in drug discovery: advances and opportunities , 2021, Nature Reviews Drug Discovery.
[24] H. Jha,et al. In silico analysis of antiviral phytochemicals efficacy against Epstein–Barr virus glycoprotein H , 2021, Journal of biomolecular structure & dynamics.
[25] M. Shakibaei,et al. Flavonoids Targeting HIF-1: Implications on Cancer Metabolism , 2021, Cancers.
[26] Yingyan Yu,et al. Perspectives on the Role of Isoliquiritigenin in Cancer , 2021, Cancers.
[27] B. Sugden,et al. Epstein–Barr Virus: How Its Lytic Phase Contributes to Oncogenesis , 2020, Microorganisms.
[28] T. Jardetzky,et al. The structural basis of herpesvirus entry , 2020, Nature reviews. Microbiology.
[29] Runliang Gan,et al. Epstein-Barr virus-associated gastric cancer: A distinct subtype. , 2020, Cancer letters.
[30] B. Damania,et al. Regulation of KSHV Latency and Lytic Reactivation , 2020, Viruses.
[31] V. Tarakanova,et al. Innate immunity and alpha/gammaherpesviruses: first impressions last a lifetime. , 2020, Current opinion in virology.
[32] T. Merghoub,et al. Silibinin down-regulates PD-L1 expression in nasopharyngeal carcinoma by interfering with tumor cell glycolytic metabolism. , 2020, Archives of biochemistry and biophysics.
[33] Kutty Selva Nandakumar,et al. Recent Research on Flavonoids and their Biomedical applications. , 2020, Current medicinal chemistry.
[34] M. Shakibaei,et al. Flavonoids in Cancer Metastasis , 2020, Cancers.
[35] J. Cohen. Herpesvirus latency. , 2020, The Journal of clinical investigation.
[36] G. Ciccarese,et al. Dermatological manifestations of Epstein‐Barr virus systemic infection: a case report and literature review , 2020, International journal of dermatology.
[37] M. Rashid,et al. Three isoflavones from Derris scandens (Roxb.) Benth and their cancer chemopreventive activity and in vitro antiproliferative effects. , 2020, Phytochemistry.
[38] P. Lieberman,et al. Epstein-Barr Virus Infection in the Development of Neurological Disorders. , 2020, Drug discovery today. Disease models.
[39] P. Kubatka,et al. Natural Products-Derived Chemicals: Breaking Barriers to Novel Anti-HSV Drug Development , 2020, Viruses.
[40] E. Grywalska,et al. Herpesviruses in Head and Neck Cancers , 2019, Viruses.
[41] YeongSeok Kim,et al. Ampelopsin Induces DR5-Mediated Apoptotic Cell Death in EBV-Infected Cells through the p38 Pathway , 2020, Nutrition and cancer.
[42] J. Hohmann,et al. Bioactive constituents of Lindernia crustacea and its anti-EBV effect via Rta expression inhibition in the viral lytic cycle. , 2019, Journal of ethnopharmacology.
[43] Yi-Fen Wang,et al. Epigallocatechin-3-gallate downregulates PDHA1 interfering the metabolic pathways in human herpesvirus 8 harboring primary effusion lymphoma cells. , 2019, Toxicology in vitro : an international journal published in association with BIBRA.
[44] M. Lamers,et al. Flavonoids as anticancer therapies: A systematic review of clinical trials , 2019, Phytotherapy research : PTR.
[45] Neil Vasan,et al. A view on drug resistance in cancer , 2019, Nature.
[46] Kwang-Hyeon Liu,et al. Quercetin Synergistically Inhibit EBV-Associated Gastric Carcinoma with Ganoderma lucidum Extracts , 2019, Molecules.
[47] C. Münz. Latency and lytic replication in Epstein–Barr virus-associated oncogenesis , 2019, Nature Reviews Microbiology.
[48] G. D’Orazi,et al. Quercetin Interrupts the Positive Feedback Loop Between STAT3 and IL-6, Promotes Autophagy, and Reduces ROS, Preventing EBV-Driven B Cell Immortalization , 2019, Biomolecules.
[49] L. Young,et al. An etiological role for the Epstein-Barr virus in the pathogenesis of classical Hodgkin lymphoma. , 2019, Blood.
[50] E. Novellino,et al. Polyphenols: A concise overview on the chemistry, occurrence, and human health , 2019, Phytotherapy research : PTR.
[51] Vinay Prasad,et al. An Overview of Cancer Drugs Approved by the US Food and Drug Administration Based on the Surrogate End Point of Response Rate. , 2019, JAMA internal medicine.
[52] Catalina Carrasco-Pozo,et al. The Anti-Cancer Effect of Quercetin: Molecular Implications in Cancer Metabolism , 2019, International journal of molecular sciences.
[53] J. Breuer,et al. Herpesvirus Infections of the Central Nervous System , 2019, Seminars in Neurology.
[54] Zhi-Ming Zheng,et al. Towards Better Understanding of KSHV Life Cycle: from Transcription and Posttranscriptional Regulations to Pathogenesis , 2019, Virologica Sinica.
[55] Hafiz M.N. Iqbal,et al. Biogenic Nanoparticle‒Chitosan Conjugates with Antimicrobial, Antibiofilm, and Anticancer Potentialities: Development and Characterization , 2019, International journal of environmental research and public health.
[56] Jeffrey N. Martin,et al. Kaposi sarcoma , 2019, Nature Reviews Disease Primers.
[57] P. Farrell. Epstein-Barr Virus and Cancer. , 2019, Annual review of pathology.
[58] F. Gao,et al. Oroxylin A inhibits Kaposi's sarcoma‐associated herpes virus (KSHV) vIL‐6–mediated lymphatic reprogramming of vascular endothelial cells through modulating PPARγ/Prox1 axis , 2018, Journal of medical virology.
[59] J. Hohmann,et al. Less Cytotoxic Protoflavones as Antiviral Agents: Protoapigenone 1′-O-isopropyl ether Shows Improved Selectivity Against the Epstein–Barr Virus Lytic Cycle , 2019, International journal of molecular sciences.
[60] Hui Teng,et al. Polyphenols and bioavailability: an update , 2019, Critical reviews in food science and nutrition.
[61] G. D’Orazi,et al. Cytotoxic Drugs Activate KSHV Lytic Cycle in Latently Infected PEL Cells by Inducing a Moderate ROS Increase Controlled by HSF1, NRF2 and p62/SQSTM1 , 2018, Viruses.
[62] Huali Yin,et al. Molecular mechanisms of EBV-driven cell cycle progression and oncogenesis , 2018, Medical Microbiology and Immunology.
[63] L. Young,et al. Activation of sterol regulatory element‐binding protein 1 (SREBP1)‐mediated lipogenesis by the Epstein–Barr virus‐encoded latent membrane protein 1 (LMP1) promotes cell proliferation and progression of nasopharyngeal carcinoma , 2018, The Journal of pathology.
[64] S. James,et al. Antiviral Therapies for Herpesviruses: Current Agents and New Directions. , 2018, Clinical therapeutics.
[65] Huan Wang,et al. Baicalein inhibits growth of Epstein-Barr virus-positive nasopharyngeal carcinoma by repressing the activity of EBNA1 Q-promoter. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[66] F. Feng,et al. Potential cancer chemopreventive and anticancer constituents from the fruits of Ficus hispida L.f. (Moraceae). , 2018, Journal of ethnopharmacology.
[67] Ya Cao,et al. (-)-Epigallocatechin-3-gallate inhibition of Epstein-Barr virus spontaneous lytic infection involves downregulation of latent membrane protein 1. , 2017, Experimental and therapeutic medicine.
[68] Hai‐Liang Zhu,et al. Isoliquiritigenin (ISL) and its formulations: potential antitumor agents. , 2018, Current medicinal chemistry.
[69] M. Nowakowska,et al. Acyclovir in the Treatment of Herpes Viruses - a Review. , 2018, Current medicinal chemistry.
[70] Chang-Yu Chen,et al. Epigallocatechin-3-Gallate Suppresses Human Herpesvirus 8 Replication and Induces ROS Leading to Apoptosis and Autophagy in Primary Effusion Lymphoma Cells , 2017, International journal of molecular sciences.
[71] G. D’Orazi,et al. Apigenin, by activating p53 and inhibiting STAT3, modulates the balance between pro-apoptotic and pro-survival pathways to induce PEL cell death , 2017, Journal of Experimental & Clinical Cancer Research.
[72] A. Garufi,et al. Oxidant species are involved in T/B-mediated ERK1/2 phosphorylation that activates p53-p21 axis to promote KSHV lytic cycle in PEL cells. , 2017, Free radical biology & medicine.
[73] Kwok Wai Lo,et al. Epstein–Barr virus infection and nasopharyngeal carcinoma , 2017, Philosophical Transactions of the Royal Society B: Biological Sciences.
[74] Yan Yuan,et al. Reactivation and Lytic Replication of Kaposi’s Sarcoma-Associated Herpesvirus: An Update , 2017, Front. Microbiol..
[75] H. Adler,et al. Herpesviruses and Their Host Cells: A Successful Liaison. , 2017, Trends in microbiology.
[76] G. D’Orazi,et al. Quercetin induces apoptosis and autophagy in primary effusion lymphoma cells by inhibiting PI3K/AKT/mTOR and STAT3 signaling pathways. , 2017, The Journal of nutritional biochemistry.
[77] A. Malik,et al. Flavonoids biosynthesis in plants and its further analysis by capillary electrophoresis , 2017, Electrophoresis.
[78] Fei Wang,et al. Wogonin as a targeted therapeutic agent for EBV (+) lymphoma cells involved in LMP1/NF-κB/miR-155/PU.1 pathway , 2017, BMC Cancer.
[79] Chung-Chun Wu,et al. Inhibition of Epstein-Barr virus reactivation by the flavonoid apigenin , 2017, Journal of Biomedical Science.
[80] W. Azab,et al. Initial Contact: The First Steps in Herpesvirus Entry. , 2017, Advances in anatomy, embryology, and cell biology.
[81] J. Ziegelbauer,et al. Kaposi sarcoma herpesvirus-associated cancers and related diseases , 2017, Current opinion in HIV and AIDS.
[82] K. Lan,et al. Kaposi's Sarcoma-Associated Herpesvirus: Epidemiology and Molecular Biology. , 2017, Advances in experimental medicine and biology.
[83] K. Jarosinski. Interindividual Spread of Herpesviruses. , 2017, Advances in anatomy, embryology, and cell biology.
[84] Sheela Chandra,et al. Flavonoids: an overview , 2016, Journal of Nutritional Science.
[85] Xiangjian Luo,et al. Epstein-Barr virus lytic reactivation regulation and its pathogenic role in carcinogenesis , 2016, International journal of biological sciences.
[86] G. D’Orazi,et al. Concomitant reduction of c-Myc expression and PI3K/AKT/mTOR signaling by quercetin induces a strong cytotoxic effect against Burkitt's lymphoma. , 2016, The international journal of biochemistry & cell biology.
[87] Hyosun Cho,et al. Anti-Cancer Effect of Quercetin in Xenograft Models with EBV-Associated Human Gastric Carcinoma , 2016, Molecules.
[88] Chung-Chun Wu,et al. Luteolin inhibits Epstein-Barr virus lytic reactivation by repressing the promoter activities of immediate-early genes. , 2016, Antiviral research.
[89] P. Qian,et al. Antiviral activity of luteolin against Japanese encephalitis virus. , 2016, Virus research.
[90] Subramani Parasuraman,et al. Overviews of Biological Importance of Quercetin: A Bioactive Flavonoid , 2016, Pharmacognosy reviews.
[91] Chung-Chun Wu,et al. EBV reactivation as a target of luteolin to repress NPC tumorigenesis , 2016, Oncotarget.
[92] Michael D. Green,et al. Epstein-Barr Virus. , 2016, Microbiology spectrum.
[93] Sherif T.S. Hassan,et al. Bioactive natural products with anti‐herpes simplex virus properties , 2015, The Journal of pharmacy and pharmacology.
[94] G. Sung,et al. Quercetin-induced apoptosis prevents EBV infection , 2015, Oncotarget.
[95] Xuanyi Wang,et al. Icaritin induces lytic cytotoxicity in extranodal NK/T-cell lymphoma , 2015, Journal of experimental & clinical cancer research : CR.
[96] A. El-Guindy,et al. Epstein-Barr Virus Lytic Cycle Reactivation. , 2015, Current topics in microbiology and immunology.
[97] G. Park,et al. ASK1/JNK-mediated TAp63 activation controls the cell survival signal of baicalein-treated EBV-transformed B cells , 2015, Molecular and Cellular Biochemistry.
[98] Ming-yong Li,et al. Interference of fisetin with targets of the nuclear factor-κB signal transduction pathway activated by Epstein-Barr virus encoded latent membrane protein 1. , 2014, Asian Pacific journal of cancer prevention : APJCP.
[99] Rong-Gang Li,et al. Fisetin inhibits migration, invasion and epithelial-mesenchymal transition of LMP1-positive nasopharyngeal carcinoma cells. , 2014, Molecular medicine reports.
[100] B. Damania,et al. KSHV: pathways to tumorigenesis and persistent infection. , 2014, Advances in virus research.
[101] A. Pandey,et al. Chemistry and Biological Activities of Flavonoids: An Overview , 2013, TheScientificWorldJournal.
[102] H. Tokuda,et al. Glycosidic Inhibitors of Melanogenesis from Leaves of Passiflora edulis , 2013, Chemistry & biodiversity.
[103] H. Mukhtar,et al. Fisetin: a dietary antioxidant for health promotion. , 2013, Antioxidants & redox signaling.
[104] A. Vianello,et al. Plant Flavonoids—Biosynthesis, Transport and Involvement in Stress Responses , 2013, International journal of molecular sciences.
[105] E. Sousa,et al. Sulfated Small Molecules Targeting EBV in Burkitt Lymphoma: From In Silico Screening to the Evidence of In Vitro Effect on Viral Episomal DNA , 2013, Chemical biology & drug design.
[106] A. Bode,et al. (-)-Epigallocatechin-3-gallate inhibition of Epstein-Barr virus spontaneous lytic infection involves ERK1/2 and PI3-K/Akt signaling in EBV-positive cells. , 2013, Carcinogenesis.
[107] Munirah Ahmad,et al. Deregulation of lipid metabolism pathway genes in nasopharyngeal carcinoma cells , 2012, Molecular medicine reports.
[108] B. Han,et al. Molecular signatures in response to Isoliquiritigenin in lymphoblastoid cell lines. , 2012, Biochemical and biophysical research communications.
[109] Huidi Jiang,et al. Pharmacokinetic study of luteolin, apigenin, chrysoeriol and diosmetin after oral administration of Flos Chrysanthemi extract in rats , 2012, Fitoterapia.
[110] J. Manosroi,et al. Anti‐Inflammatory and Anti‐Tumor‐Promoting Effects of 5‐Deprenyllupulonol C and Other Compounds from Hop (Humulus lupulus L.) , 2012, Chemistry & biodiversity.
[111] H. Tokuda,et al. Cytotoxic Activities and Anti‐Tumor‐Promoting Effects of Microbial Transformation Products of Prenylated Chalcones from Angelica keiskei , 2012, Chemistry & biodiversity.
[112] Ya-lin Chen,et al. EGCG debilitates the persistence of EBV latency by reducing the DNA binding potency of nuclear antigen 1. , 2012, Biochemical and biophysical research communications.
[113] H. Tokuda,et al. Conjugates of 3α-methoxyserrat-14-en-21β-ol (PJ-1) and 3β-methoxyserrat-14-en-21β-ol (PJ-2) as cancer chemopreventive agents. , 2011, European journal of medicinal chemistry.
[114] F. Chang,et al. Inhibition of the Epstein-Barr virus lytic cycle by protoapigenone. , 2011, The Journal of general virology.
[115] Ethel Cesarman,et al. Kaposi's sarcoma and its associated herpesvirus , 2010, Nature Reviews Cancer.
[116] D. Ganem,et al. Viral latency and its regulation: lessons from the gamma-herpesviruses. , 2010, Cell host & microbe.
[117] S. T. Hosseini,et al. Cancer chemopreventive activity of diversin from Ferula diversivittata in vitro and in vivo. , 2010, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[118] M. Ackermann. Pathogenesis of gammaherpesvirus infections. , 2006, Veterinary microbiology.
[119] J. Kutok,et al. Spectrum of Epstein-Barr virus-associated diseases. , 2006, Annual review of pathology.
[120] D. Treutter. Significance of Flavonoids in Plant Resistance and Enhancement of Their Biosynthesis , 2005, Plant biology.
[121] M. Itoigawa,et al. Anti-tumor-promoting effects of isoflavonoids on Epstein-Barr virus activation and two-stage mouse skin carcinogenesis. , 1999, Cancer letters.